
China · Pharmaceuticals startup
Shanghai Cell Therapy Group is an innovative company based in China, founded in 2013.
Funding reportedLast round: Series D
Shanghai Cell Therapy Group is an innovative company based in China, founded in 2013.
It specializes in cell technology and is recognized as the first company in China to cover the full value chain of cell medical health. The company focuses on cell rejuvenation, aiming to enhance human longevity through its "Shangxi Longevity Revolution" plan, which includes initiatives for developing advanced cell therapy technologies and products. The group offers a range of services, including cell storage, tumor medical services, cell drug research and development, and cell energization. It operates the Shanghai University Affiliated Mengchao Cancer Hospital, which provides comprehensive cancer care, and the Baize Medical Laboratory, specializing in multi-omics testing for health management. With facilities in multiple regions, including Beijing, Henan, Zhejiang, and Hainan, the company is well-positioned to serve over 20 core cities in China and has an international presence in Menlo Park, California.
Funding, as reported
What they build
Known for
dlbcl targetinghealth caremolecular diagnosticsmrna deliverybiotechnology researchcell therapymedical researchbiotech collaborationslightningcar-tpd1 checkpoint blockadehospital & health caremedicalb2chealthbiotechnologyhigh-quality life extension
Built with from their website
NetEase Enterprise MailWOWBaiduViewport MetaMobile FriendlyjQuerySwiperICPHTTP/3GlobalSign
HSTSNginxPHPBaidu Ads
Add your raise, your deck and your story, and put Shanghai Cell Therapy Group in front of investors. Or tell us what we have wrong.